Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sineád M. Nyhan"'
Autor:
Eric A. Gehrie, Chun W. Choi, Charles J. Love, Nadia B. Hensley, Kevin R. Merkel, Steven M. Frank, Brian C. Cho, Sineád M. Nyhan
Publikováno v:
Transfusion. 60:1741-1746
Background Transvenous lead extractions (TLEs) have increased in number due to an increased prevalence of cardiac implantable devices. Bleeding complications associated with TLEs can be catastrophic, and many institutions order blood components to be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e6b2f9103f2b4a532a49b7d1607cb79
https://doi.org/10.1111/trf.15914
https://doi.org/10.1111/trf.15914
Publikováno v:
Journal of cardiothoracic and vascular anesthesia. 36(6)
Pulmonary hypertension (PH) is a disease that has many etiologies and is particularly prevalent in patients presenting for cardiac surgery, with which it is linked to poor outcomes. This manuscript is intended to provide a comprehensive review of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cc950b4d5bdbc1d1635a68cc3b4280d
https://pubmed.ncbi.nlm.nih.gov/35181235
https://pubmed.ncbi.nlm.nih.gov/35181235
Autor:
Gautam Sikka, Sineád M. Nyhan, Artin A. Shoukas, Ayushi Ahuja, Anthony R. White, Jorge A. Uribe, Jochen Steppan, Dan E. Berkowitz
Publikováno v:
Anesthesia & Analgesia. 115:1290-1295
BACKGROUND Vasopressin is frequently used to treat catecholamine-resistant vasodilatory shock. It enhances the vasoconstrictor effects of catecholamines at concentrations of vasopressin that have none or only minimal intrinsic pressor effects. Howeve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05c7c99a50d281f964550cf3d9249a01
https://doi.org/10.1213/ane.0b013e3182691c11
https://doi.org/10.1213/ane.0b013e3182691c11
Autor:
Artin A. Shoukas, Gaurav Gupta, Alexandre M. Benjo, Jochen Steppan, Sineád M. Nyhan, Benjamin D. Levine, Sungwoo Ryoo, Craig Lussman, Laxsmi Pellakuru, Anthony R. White, Huang Tran, João Paulo Lima Daher, Viachaslau Barodka, Dan E. Berkowitz
Advanced glycation end-products (AGEs) initiate cellular inflammation and contribute to cardiovascular disease in the elderly. AGE can be inhibited by Alagebrium (ALT), an AGE cross-link breaker. Moreover, the beneficial effects of exercise on aging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34a2d53018b3770cf43fcff3d1e8d1a5
https://europepmc.org/articles/PMC4359688/
https://europepmc.org/articles/PMC4359688/
